Updated international consensus report on the investigation and management of primary immune thrombocytopenia

Abstract

Abstract Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel screened, reviewed, and graded the studies and formulated the updated consensus recommendations based on the new data. The final document provides consensus recommendations on the diagnosis and management of ITP in adults, during pregnancy, and in children, as well as quality-of-life considerations.

Keywords

Affiliated Institutions

• Harvard University US
• Assistance Publique – Hôpitaux de Paris FR
• Hospital Universitario de Burgos ES
• Azienda Sanitaria Universitaria Integrata di Trieste IT
• Canadian Blood Services CA
• Hammersmith Hospital GB
• University College Hospital GB
• University College London GB
• Prince of Wales Hospital HK
• St George Hospital AU
• Osaka University Hospital JP
• University of Oxford GB
• University of Oslo
• Barts Health NHS Trust GB
• Weill Cornell Medicine US
• Seattle Cancer Care Alliance US
• UNSW Sydney AU
• Royal Manchester Children's Hospital GB
• Centre Hospitalier Universitaire Henri-Mondor FR
• Ospedale San Bortolo IT
• Massachusetts General Hospital US
• Qilu Hospital of Shandong University CN
• Queen Mary University of London GB
• Chinese University of Hong Kong HK
• Université Paris-Est Créteil FR
• McMaster University CA
• Cornell University US
• University of Washington US
• Royal London Hospital GB
• Oxford BioMedica (United Kingdom) GB

Related Publications